Mylan’s EpiPen School Sales Trigger N.Y. Antitrust ProbeBy and
Drugmaker has been criticized over increase in EpiPen price
Probe will focus on Mylan’s contracts with New York schools
New York state’s top cop opened an antitrust investigation into Mylan NV, saying the embattled drugmaker may have ripped off local school systems that purchased life-saving EpiPen shots for students.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.